View in EDS HTML Full Text PDF Full Text

Correction: Receptor tyrosine kinase inhibitor sunitinib as novel immunotherapy to inhibit myeloid-derived suppressor cells for treatment of endometriosis.

Saved in:
Bibliographic Details
Title: Correction: Receptor tyrosine kinase inhibitor sunitinib as novel immunotherapy to inhibit myeloid-derived suppressor cells for treatment of endometriosis.
Authors: He Y; Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., Hung SW; Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., Liang B; Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., Zhang R; Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., Gao Y; Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., Chu CY; Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., Zhang T; Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., Xu H; Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., Chung JPW; Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., Wang CC; Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.; School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.; Chinese University of Hong Kong-Sichuan University Joint Laboratory in Reproductive Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.
Source: Frontiers in immunology [Front Immunol] 2025 Nov 24; Vol. 16, pp. 1741271. Date of Electronic Publication: 2025 Nov 24 (Print Publication: 2025).
Publication Type: Published Erratum
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41368639
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Correction: Receptor tyrosine kinase inhibitor sunitinib as novel immunotherapy to inhibit myeloid-derived suppressor cells for treatment of endometriosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22He+Y%22">He Y</searchLink>; Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Hung+SW%22">Hung SW</searchLink>; Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Liang+B%22">Liang B</searchLink>; Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Zhang+R%22">Zhang R</searchLink>; Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Gao+Y%22">Gao Y</searchLink>; Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Chu+CY%22">Chu CY</searchLink>; Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Zhang+T%22">Zhang T</searchLink>; Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Xu+H%22">Xu H</searchLink>; Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Chung+JPW%22">Chung JPW</searchLink>; Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Wang+CC%22">Wang CC</searchLink>; Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.; School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.; Chinese University of Hong Kong-Sichuan University Joint Laboratory in Reproductive Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2025 Nov 24; Vol. 16, pp. 1741271. <i>Date of Electronic Publication: </i>2025 Nov 24 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41368639
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2025.1741271
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1741271
    Titles:
      – TitleFull: Correction: Receptor tyrosine kinase inhibitor sunitinib as novel immunotherapy to inhibit myeloid-derived suppressor cells for treatment of endometriosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: He Y
      – PersonEntity:
          Name:
            NameFull: Hung SW
      – PersonEntity:
          Name:
            NameFull: Liang B
      – PersonEntity:
          Name:
            NameFull: Zhang R
      – PersonEntity:
          Name:
            NameFull: Gao Y
      – PersonEntity:
          Name:
            NameFull: Chu CY
      – PersonEntity:
          Name:
            NameFull: Zhang T
      – PersonEntity:
          Name:
            NameFull: Xu H
      – PersonEntity:
          Name:
            NameFull: Chung JPW
      – PersonEntity:
          Name:
            NameFull: Wang CC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 24
              M: 11
              Text: 2025 Nov 24
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1